Last week the NHS released their long term plan with funding of £20.5 billion backing the new plans up to 2023, of course research and innovation features within the plan which is summarised below.
Research and innovation are key to both the NHS and UK economy. ‘Research-active’ hospitals have lower mortality rates with patients benefiting from earlier diagnosis, more effective treatments and faster recovery. The government plans to treble it’s industry contract and R&D collaborative research with the NHS over the next ten years to nearly £1 billion.
The NHS will be working to increase the number of people registered to participate in health research to 1 million by 2023/24, one way of doing this will be by allowing people to register their interest via an app by 2020.
There is a particular focus on investing in genomics research with the aim to be the first national health care system to offer whole genome sequencing as part of routine care. During 2019 seriously ill children who are likely to have rare genetic disorders, children with cancer, and adults suffering from certain rare conditions or specific cancers, will begin to be offered whole genome sequencing.
Uptake of proven, affordable innovations will be accelerated through a new Medtech funding mandate. This applies to health tech products (other than pharmaceuticals) assessed as cost saving by NICE. The number of NICE evaluations will also be significantly increased giving greater scope for assessment of digital products in particular.
For more information about the NHS long term plan you can visit the plans here.